H.C. Wainwright Global Investment Conference 2023
An important event in the global Life Sciences. Attended by >500 companies.
Global Bioprocessing Summit 4.0 2023
Keynotion Global Bioprocessing Summit brings together leading bioprocessing scientists and engineers to share day-to-day challenges and practical solutions for the development, manufacturing and quality of antibodies, vaccines and gene therapies. This world class conference is a mixture of Comprehensive Workshop, detailed case studies and interactive discussions in cell culture, scale-up, continuous Biomanufacturing, recovery, purification, process and product characterization, and formulation.
GCFF Virtual Conference 2023 – Healthcare Investment (Asia Pacific)
The GCFF Virtual Conference 2022 – Healthcare Investment Conference (Asia Pacific) will be the premier event to connect HNW, institutional and industrial investors in Asia Pacific to the latest investment opportunities in the healthcare sector.
Future of Healthcare Investor Forum 2023
EUROTOX 2023
Toxicology – multidisciplinary science leading to safer and sustainable life – Our mission is to foster the science and education of toxicology, and influence regulatory and policy frameworks to promote the safety of humans, animals and the environment, and protect global health.
ESMO Congress 2023 (European Society for Medical Oncology)
The ESMO Congress is the yearly appointment in Europe for nearly 30,000 clinicians, researchers, oncology nurses, patient advocates, journalists, and representatives of the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology, and translate science into better cancer patient care. Medical/clinical oncologists, basic translational researchers, oncology nurses, all other oncology professionals, patient advocates, journalists, healthcare industry representatives, policy decision makers, regulators.
ERS International Congress 2023 (ERS 2023) (European Respiratory Society)
The ERS Congress is the once-a-year occasion when the world’s respiratory experts come together, to present and discuss the latest scientific and clinical advances across the entire field of respiratory medicine. It welcomes a global audience of respiratory focused professionals inclusive of clinicians, scientists and researchers, and allied healthcare professionals. As the ERS Congress reaches its 32nd year, we invite you to register for this year’s event – our first to offer both in-person or online attendance.
DDW 2023 (Digestive Disease Week)
Recognized as one of the top 50 medical meetings by HCEA, Digestive Disease Week® (DDW) is the world’s largest gathering of physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
DCAT Week
DCAT Week is not a Trade Show. It is a multifaceted event where DCAT Member Companies have the opportunity to reserve meeting space through the DCAT organization to conduct high-level, private, strategic meetings with customers and suppliers.
Hanson Wade Tumor Myeloid-Directed Therapies Summit 2023
Returning in 2022, the Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment. This is your ultimate forum to identify, validate, and clinically progress myeloid targets to expand the oncologists toolkit and realize better responses by engaging myeloid anti-tumor function. Designed for experts working directly on myeloid-directed therapies, and those in adjacent immuno-oncology fields, from cell therapy to checkpoint and engager development. If you’re scratching your head in attempt to enhance efficacy in solid tumors and overcome barriers in the microenvironment, this is your 500-foot view of the intricate pathways, interactions, and novel target development in the tumor microenvironment. Deep-dive into myeloid biology, guided by 27+ industry Gurus from the likes of Pionyr Immunotherapeutics, Gilead Sciences, Merck, Verseau Therapeutics, Carisma Therapeutics, Pfizer and many more. With targets such as TREM1 and TREM2 making waves in the clinic, analysis of CD47 candidates back-translating to next-generation therapies, and novel dendritic cell candidates such as FTL3 in development, this 3-day myeloid extravaganza is unmissable for anyone looking to unlock better therapeutic potential through the myeloid compartment.